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Renal vascular induction of TGF.j32 and renin by potassium depletion.
Recently, we have found that transforming growth factor (TGF)-f2 and
renin are abundantly expressed in the juxtaglomerular apparatus (JGA)
of dehydrated mice. Since potassium (K) depletion also stimulates
renin and induces hypertrophy of the JGA, we examined the ability of
this maneuver to stimulate TGF-f3 isoforms and renin in renovascular
tissue and the JGA of young rats. Sprague-Dawley rats (50 5 g) were
fed either a control diet or a potassium-deficient diet (<0.05% K) for
7, 16, or 21 days. As a control for TGF-J3 and renin stimulation, an
additional group of animals was fed a normal diet but was water
deprived for three days, Potassium-depleted animals experienced se-
vere growth retardation but kidney weight increased significantly.
Potassium depletion induced both TGF-/32 and renin immunoreactivity
in renal arterioles and the JGA but had no effect on TGF-f3l and
TGF-133 isoforms. To determine the role of circulatingangiotensin II in
the stimulation of TGF-/32 by potassium depletion, a group of potassi-
um-depleted rats received enalapril (100 mg/liter) in the drinking water.
The addition of converting enzyme inhibitor increased both the inten-
sity of TGF-/32 and renin staining as well as the number of cells
positively stained. Our results demonstrate that K depletion induces
TGF-f32 and renin in renal arterioles and in the JGA. Furthermore,
circulating angiotensin H is not responsible for the increase in the local
expression of TGF-p2. These findings suggest that TGF-/32 may be an
important mediator of JGA hypertrophy. The simultaneous induction of
TGF-132 with renin suggests that these factors may be coregulated.
An increase in the number of renin-containing cells in the
juxtaglomerular apparatus (JGA) and renal arterioles has been
found during development [1] and when renin synthesis is
stimulated by potassium depletion, salt depletion, adrenalec-
tomy, or by treatment with angiotensin converting enzyme
inhibitors [2—6]. In adult and pediatric patients, Bartter's syn-
drome and renal artery stenosis [5] are associated with an
increase in renin-containing cells. Under these conditions,
granular cells have been identified in extraglomerular regions,
such as the cortical, radial (interlobular), and arcuate arteries
[1-6].
Renin secreting cells undergo hypertrophy when renin is
stimulated [2, 3]. Thus, the JGA granular cells as well as
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renin-secreting vascular smooth muscle cells increase in size.
Renin stimulation is often associated with an increase in the
number of secretory granules and thickness of the afferent
arteriolar wall. The molecular mechanisms responsible for
these changes, however, remain unknown but suggest the
presence of a co-regulated growth factor.
The vasoactive peptide angiotensin II (Ang II) is a co-mitogen
for several renal mesangial cells and vascular smooth muscle
cells [7—11]. Therefore, increased circulating levels of Ang II
could induce myointimal hyperplasia and renal vascular smooth
muscle cell growth. Angiotensin is unlikely, however, to stim-
ulate granulogenesis and JGA hypertrophy since Ang II inhibits
renin synthesis [12]. Alternatively, other growth factors, par-
ticularly TGF-/3, which is induced in the JGA in the setting of
severe dehydration [13], could be responsible for both hyper-
granulation and hypertrophy of the JGA and renal arterioles.
TGF-f3s are known to modulate a number of cellular func-
tions including proliferation, differentiation, protein synthesis,
and hormonal release by several cell types [14—17]. TGF-J31 and
TGF-/32 mRNAs are found in glomerular mesangial and vascu-
lar smooth muscle cells [18—19]. In addition, Ang II stimulates
TGF-131 mRNA expression in rat vascular smooth muscle cells,
an effect which is thought to be responsible for the hypertrophic
response of these cells to Ang II [19]. Water deprivation, which
increases circulating levels of Ang II, induces accumulation of
both renin and TGF-/32 in JGA of mice [13]. Water deprivation,
however, is associated with changes in osmolarity, increased
serum sodium and potassium concentrations, as well as in-
creased circulating Ang II. Thus, the factors responsible for
renin and TGF-f3 induction remain unclear.
In the present study, we investigated the effects of potassium
depletion on the expression of renin and transforming growth
factor J3 isoforms in JGA and renal arterioles of young rats.
Young rats were selected because the renin-angiotensin system
of young animals is particularly sensitive to changes in electro-
lyte imbalance. Potassium depletion stimulates circulating Ang
II and induces JGA hypertrophy but, in contrast to water
deprivation, does not alter serum osmolarity or sodium concen-
tration. We compared the effects of potassium depletion with
water deprivation in young rats and then explored whether
circulating Ang II stimulates TGF-13 by treating potassium-
depleted rats with angiotensin converting enzyme inhibitors.
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Fig. 1. Localization of renin in rat kidney by immunohistochemistry. A. Control rat kidney demonstrates staining for renin in JGA (magnification
320x). B. Kidney from a 16 day potassium-depleted rat demonstrates intense staining of JGA and recruitment of renin producing cells in
vasculature, indicated by the arrow head (magnification 320x). Kidney from a potassium-depleted rat treated with enalapril demonstrates a marked
increase in renin staining, an increase in the size of renin secreting cells, and recruitment of immunoreactive cells in renal arterioles (C.
magnification 320x; D. magnification 160x).
We found that potassium depletion stimulated renin and
TGF-/32 in the JGA. Induction of TGF-f32 was not dependent
upon circulating levels of Ang II. In fact, inhibition of Ang II
increased the expression of renin and TGF-132 at these sites.
When angiotensin converting enzyme was inhibited in the
presence of potassium depletion, juxtaglomerular hypertrophy
was more apparent. These findings suggest that TGF-J32 may be
an important mediator of JGA hypertrophy, and that TGF-f32
and renin may be coregulated.
Methods
Experimental design
Male Sprague-Dawley rats, 50 5 grams body weight, were
purchased from Taconic Farms (Germantown, New York,
USA). Animals were housed individually in a temperature
controlled room (24°C) with a 12 hour onIl2 hour off lighting
schedule. Three groups of 5 animals each were studied. All rats
were given food and water ad libitum. Group 1 was fed a
standard diet containing 0.3 g% NaCl and 0.5 g% potassium.
Group 2 was fed a potassium-deficient diet containing <0.05 g%
K and 0.3 g% NaCI. This diet is known to stimulate renin
synthesis [20—22]. Group 3 was fed the same potassium-defi-
cient diet but enalapril maleate (Merck Sharp & Dohme,
Rahway, New Jersey, USA) 100 mgfliter was added to the
drinking water. Standard and modified rat chow were obtained
from ICN Nutritional Biochemical (Cleveland, Ohio, USA).
Kidneys were harvested at 7, 16, and 21 days for immunohis-
tochemical analysis. Since water deprivation is known to in-
duce TGF-/32 in JGA and renal vasculature of adult mice [13],
we water deprived an additional group of young rats of similar
age and weight for three days as a positive control group.
Plasma samples were collected in ice-cold heparinized tubes
to measure plasma electrolytes and osmolarity in treated rats.
EDTA-containing tubes were used to collect samples for the
measurement of plasma renin activity. Sodium and potassium
concentration were measured using a KNA 2 Sodium-Potas-
sium analyzer (Radiometer, Copenhagen, Denmark). Plasma
renin activity was determined by radioimmunoassay [231. Se-
rum osmolarity was measured using an Advanced Digit Matic
osmometer model 3 DII (Advanced Instruments, Needham
Heights, Massachusetts, USA).
Antibodies
Affinity-purified rabbit polyclonal antibodies directed against
peptide sequences unique to TGF-/31, TGF-/32 and TGF-f33
were prepared, and have been shown previously to have
w
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Fig. 2. Localization of TGFI32 in rat kidney by immunohistochemistry. A. Control rat kidney demonstrates faint staining in occasional cortical
tubular cells and no staining in JGA or renal arterioles (magnification 320x). B. Kidney from a 16 day potassium-depleted rat demonstrates faint
staining in cortical tubular cells and localized staining in JGA and renal arterioles (magnification 320X). C. Kidney from a potassium-depleted rat
treated with enalapril demonstrates intense staining in JGA (magnification 320x) and recruitment of TGFf32 immunoreactive cells along renal
arterioles (D: magnification 160x).
isoform specificity [24—26]. The peptide sequences were from
the latency-associated peptide of the TGF-pl precursor and
from the mature forms of TGF-p2 and TGF-/33. Anti-rat renin
polyclonal antibody was a gift of Dr. T. Inagami (Vanderbilt
University, Nashville, Tennessee, USA). Antiserum was di-
luted 1:2500 in PBS containing 3% BSA. The specificity and
characteristics of this antibody have been reported previously
[27, 28].
Histochemistry
Kidneys were weighed, fixed in zinc formalin (Anatec, Battle
Creek, Michigan, USA), and embedded in paraffin. TGF-/3
isotypes were localized in 5 j.m sections using an avidin-biotin-
peroxidase kit (Vector Laboratories, Inc., Burlingame, Califor-
nia, USA). Deparafinized sections were digested with hyal-
uronidase (1 mg/mi, Calbiochem-Boehnng Corp., La Jolla,
California, USA) and blocked with 5% normal goat serum, 1%
BSA fraction V (Miles Laboratories Inc., Naperville, Illinois,
USA) and 1% ovalbumin (Fluka, Inc., Ronkonkoma, New
York, USA). Sections were then incubated with primary anti-
bodies (4 to 10 g/ml for TGF-/3 antibodies or 1/5,000 dilution of
anti-renin antiserum) in Tris-buffered saline (TBS) containing
1% BSA for 16 hours at 4°C. Sections were washed in TBS/
0.1% BSA and then incubated with biotinylated goat anti-rabbit
IgG followed by avidin-biotin complex. The sections were
incubated in 0.5 mg/mi 3,3'-diaminobenzidine (Sigma Chemical
Co., St Louis, Missouri, USA) and in 0.1% hydrogen peroxide
for three to five minutes and counterstained with Mayer's
hematoxylin. As a control, the first antibody was omitted and
replaced by an equivalent concentration of nonimmune rabbit
IgG. The specificity of the primary TGF-f32 antibody has been
demonstrated previously by complete blocking in the presence
of a 20-fold molar excess of the immunizing peptide [13].
Statistical analysis
Results were expressed as mean SEM and significance was
analyzed by analysis of variance. P values of less than 0.05
were considered statistically significant.
Results
After two weeks, the two groups of rats fed a potassium-
depleted diet weighed less than control animals: control animals
weighed 108 7 g, potassium-depleted rats weighed 65 8 g,
and potassium-depleted rats treated with enalapril weighed 62
.
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Fig. 3. Colocalization of renin and TGF-J32 in
vascular tissue. In potassium-depleted animals
treated with enalapril, recruitment of cells that
were identified by both renin (A) and TGF-132
(B) immunoreactivity could be found along
renal arterioles (magnification 640x).
6 g, respectively (P < 0.05, potassium-depleted vs. control).
In contrast to body weight, there was no significant difference in
absolute kidney weight between the three groups: control 0.51
0.05 g, potassium-depleted 0.47 0.04 g, and potassium-
depleted treated with enalapril 0.48 0.05 g, respectively.
When the weight of both kidneys was expressed as a percentage
of body weight, however, kidney weight was significantly
increased in the potassium-depleted groups (control 0.47%,
potassium-depleted 0.72%, and potassium-depletion treated
with enalapril 0.77%).
As expected, serum potassium was decreased in potassium-
depleted animals when compared to control animals: 2.3 mEq/
liter 0.1 versus 4.4 0.1 mEq/liter. Enalapril treatment of
potassium-depleted rats produced an intermediate serum potas-
sium concentration of 3.5 0.4 mEq/liter, presumably from the
loss of angiotensin-stimulated aldosterone secretion. Serum
sodium and osmolarity were not significantly different between
all groups: (serum sodium in control 139 0.9, in potassium
depletion 136 1.2, and in potassium depletion plus enalapril
137 1.3 mEq/liter; serum osmolarity in control 298 1.5, in
potassium depletion 293 2.1, and in potassium depletion plus
enalapril 294 3.1 mOsm/liter). In contrast, water deprivation
significantly increased serum potassium (6.4 0.3 mEq/liter),
serum sodium (152 2 mEqlliter), and serum osmolarity (309
2 mEq/liter) when compared to all other groups.
As has been shown previously, potassium depletion induced
an increase in plasma renin activity. Potassium depletion alone
increased plasma renin activity sixfold, and when combined
with enalapril treatment, plasma renin activity increased eight-
fold above control. Plasma renin activity of rats drinking water
ad libitum was 2.7 0.4 nglml/hr, plasma renin activity of
potassium-depleted rats was 17.3 2 ng/mllhr, and plasma
renin activity of potassium-depleted rats receiving enalapril in
the drinking water was 25 4 ng/mllhr (P < 0.05). Water
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Fig. 4. Localization of renin in rat kidney by
immunohistochemistry (magnification 640 x).
Hypertrophy of the JGA from a potassium-
depleted enalapril-treated rat. JGA cells are
increased in size and renin content.
deprivation increased plasma renin activity threefold (9.2 1
nglmllhr) when compared to control rats (2.7 0.4 nglml/hr; P
<0.05).
To localize the sites of immunoreactive renin within kidney,
renal tissue was examined by immunohistochemistry using
anti-renin antibodies (Fig. 1). In control animals, immunoreac-
tive renin staining was limited to the juxtaglomerular cells (Fig.
lA). In potassium-depleted rats, increased renin staining was
detected in the JGA (Fig. lB), but, in addition, potassium
depletion increased the number of renin immunoreactive cells
in renal arterioles as well (arrow). Dehydrated rats showed JGA
renin staining similar to that of potassium-depleted rats (data
not shown). Treatment with enalapril dramatically increased
the number of renin immunoreactive cells in JGA and along
renal arterioles (Fig. 1 C and D).
At all time points, distribution of TGF-132 was similar to that
of renin following potassium depletion (Fig. 2). The intensity of
renin and TGF-/32 immunostaining correlated directly with the
duration of treatment. Increased renin and TGF-p2 were de-
tected after seven days and maximal immunostaining was
present after 21 days (data not shown). No significant staining
was present in JGA or vascular smooth muscle cells of control
animals (Fig. 2A). Tubule epithelial cells from control animals,
however, exhibited faint staining with anti-TGF-/32 antibody.
Potassium depletion induced a significant recruitment of cells
that were immunoreactive for TGF-p2 in the JGA (Fig. 2B).
Dehydrated rats showed similar staining in JGA (data not
shown). Potassium-depleted animals treated with enalapril had
further recruitment of immunoreactive cells in the JGA and
smooth muscle cell layer of periglomerular renal arterioles (Fig.
2 C and D). At higher magnification, recruitment of renin (Fig.
3A) and TGF-f32 (Fig. 3B) immunoreactive cells along renal
arterioles was clearly visible in potassium-depleted rats treated
with enalapril. Furthermore, potassium depletion in combina-
tion with enalapril induced marked juxtaglomerular hypertro-
phy (Fig. 4).
In contrast to the clear differences in localization of TGF-f32,
the staining patterns with anti-TGF-/31 and anti-TGF-133 anti-
bodies were heterogeneous, with some tubules demonstrating
focal areas of slightly greater reactivity than others. These
changes were highly variable and no clear pattern emerged. In
all groups, staining of tubular epithelial cells with TGF-f31
antibody was generally diffuse with some focal areas of greater
staining (Fig. 5 A, B, and C). A similar staining pattern was
detected with anti-TGF-/33 antibody (Fig. 5 E, F, and G).
Discussion
Potassium depletion induces a complex physiologic response
to retain potassium and maintain intracellular electrolyte integ-
rity. Increasingly, potassium deficiency has been recognized to
produce other responses that may contribute to disease includ-
ing an increase in systemic blood pressure [29], stimulation of
plasma renin activity [2], and juxtaglomerular hypertrophy [3].
The molecular mechanisms responsible for these changes,
however, remain obscure.
In the present study, we demonstrated that potassium deple-
tion or water deprivation induced accumulation of TGF-f32 and
renin in juxtaglomerular cells and renal arterioles in young rats.
In contrast to the clear colocalization of TGF-f32 with renin in
JGA and renal arterioles, immunostaining for TGF-131 and
TGF-/33 in renal tubules was not significantly different between
control and treated animals. Water deprivation was associated
Fig. 5. Localization of TGF-f31 and TGF-/33 expression in rat kidney by immunocytochemistry. Immunoreactive TGF-131 can be detected in a
heterogeneous pattern in tubular epithelial cells of (A) controls, (B) potassium-depleted animals, and (C) potassium-depleted animals treated with
enalapril (magnification 160x). In all groups, some cortical tubular cells stained more intensely than others. Control nonimmune serum IgG was
negative (D). Immunoreactive TGF-/33 was found in the renal tubular epithelial cells in (E) control, (F) potassium-depleted, and (G)
potassium-depleted animals treated with enalapril (magnification 160x). Staining was absent in potassium-depleted animals treated with
nonimmune serum IgG (H). Some cortical cells were stained more intensely than others.
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with an increased in serum osmolarity, sodium and potassium
concentration, and circulating Ang II level. In contrast, potas-
sium depletion induced a different physiologic response without
significantly changing serum osmolarity and sodium concentra-
tion. Furthermore, no significant kidney growth was detected
after three days of water deprivation, whereas potassium de-
pletion induced both kidney growth and JGA hypertrophy.
Despite the different physiologic responses associated with
renin stimulation, the pattern of simultaneous induction of renin
and TGF-p2 expression in JGA and vascular smooth muscle
remained.
Potassium depletion and dehydration both increase plasma
renin activity and circulating levels of Ang II. Since Ang II
induces TGF-p expression as well as vascular smooth muscle
cell hypertrophy, it is possible that the observed responses to
potassium depletion could be mediated by Ang II alone. To
exclude this possibility, we treated potassium-depleted animals
with an angiotensin converting enzyme inhibitor to decrease
circulating levels of Ang II. We failed to detect a reduction in
immunostaining for TGF-J32, and angiotensin converting en-
zyme inhibition was actually associated with greater recruit-
ment of TGF-/32 and renin immunoreactive cells as well as
marked juxtaglomerular hypertrophy. It is likely that convert-
ing enzyme inhibition induces several other confounding factors
that may also affect cell growth and renin and TGF-/32 synthesis
including kinins and products of arachidonic acid metabolism.
In summary, however, this finding suggests that circulating Ang
II does not mediate the effects of potassium depletion on
TGF-j32 production, and strongly suggests that TGF-/32 and
renin are coregulated in rodents.
Ang II is known to stimulate smooth muscle cell growth
during development and after vascular injury [8, 30]. It has been
postulated that the effects of Ang II on smooth muscle cell
growth are mediated by TGF-/3 [31]. We have demonstrated,
however, that angiotensin converting enzyme inhibitors further
stimulate TGF-f32 through a mechanism that is distinct from
Ang II. Since accumulation of TGF-/32 may potentiate the
hypertrophy response of renal vascular tissue, it is possible that
the use of angiotensin converting enzyme inhibitors under these
circumstances may not be beneficial and may actually be
harmful.
Previous studies have demonstrated that TGF-f32 mRNA is
present in vascular smooth muscle cells, granular cells from the
JGA, and renal mesangial cells [18—19, 32]. Thus, increased
production of TGF-f32 at these sites most likely represents
increased local synthesis. Immunoreactive TGF-132 observed in
JGA and smooth muscle cells, however, may represent the
accumulation of this growth factor from reduced secretion or
increased uptake of TGF-/32 from distal sites. Further studies to
localize TGF-/32 mRNA by in situ hybridization will help to
clarify this issue.
The remarkable colocalization of TGF-132 and renin during
dietary potassium depletion strongly suggests a regulatory
interaction. Although speculative, the presence of TGF-j32 in
renin-producing cells suggests that TGF-p2 may induce hyper-
trophy of renin producing cells in smooth muscle and the JGA,
and may contribute to the differentiation of cells along the renal
arteriole into a renin secreting phenotype. Indirect support for
this hypothesis comes from several laboratories. TGF-/3s ap-
pear to play an important role in the development of vascular
smooth muscle hypertrophy in other conditions such as hyper-
tension [19, 33, 34]. Since renin is synthesized, stored, and
released from differentiated smooth muscle cells, TGF-/3 may
also increase granulogenesis of renin secreting cells. TGF-p
peptides, for example, stimulate renin release in the adrenal
gland [35] and TGF-/3 can regulate other hormonal systems as
well [15—17]. Thus, TGF-f3 is an excellent candidate for the
growth factor responsible for hypertrophy of renin-secreting
cells as well as the growth factor responsible for differentiation
of non-renin secreting vascular smooth muscle into a renin-
secreting cell.
In conclusion, we have demonstrated that potassium defi-
ciency induces the expression of renin and TGF-/32 in JGA and
along renal arterioles. This effect of potassium deficiency is
enhanced by angiotensin converting enzyme inhibition. These
findings suggest that TGF-/32 may be an important modulator of
JGA function and renal vascular cell growth and may well affect
renin synthesis and secretion as well. The colocalization of
renin with TGF-132 suggests that both systems interact in
potassium homeostasis and that TGF-/32 may have an as yet
undefined role in maintaining electrolyte balance. Furthermore,
vascular TGF-/32 expression, like renin, may be developmen-
tally regulated and participate as a development growth factor
for renin-secreting cells [36, 37]. Thus, renin and TGF-f.32 may
have complementary roles during kidney growth, vascular
development, and disease.
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